Iranian Journal of Medical Sciences

Document Type : Original Article(s)


1 Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

2 Jefferson Comprehensive Epilepsy Center, Department of Neurology, Thomas Jefferson University, Philadelphia, Pennsylvania, PA, USA


Background: Previous studies have shown that patients with epilepsy (PWE) perceived significant disruption in the quality and provision of care due to the coronavirus disease 2019 (COVID-19) pandemic. The present study aimed to investigate the effect of this pandemic on seizure control status and changes in seizure frequency in PWE. 
Methods: A consecutive sample of adult PWE registered in the database of Shiraz Epilepsy Center (Shiraz, Iran) was included in the study. In July 2021, phone interviews were conducted with all selected patients. Information such as age, sex, last seizure, seizure type, and frequency during the 12 months before the study, and history of COVID-19 contraction was extracted. The seizure control status of the patients in 2019 (pre-pandemic) was compared with that during the COVID-19 pandemic. Data were analyzed using SPSS software with the Fisher’s exact test and Pearson’s Chi squared test. P<0.05 was considered statistically significant. 
Results: A total of 158 patients were included in the study, out of which 62 (39.2%) patients had a stable seizure control status, 47 (29.7%) had fewer seizures, and 50 (31.6%) had more seizures. Breakthrough seizures were reported by 32 (34.4%) patients. Seizure frequency increased in 18 (27.7%) and decreased in 46 (70.7%) patients.
Conclusion: Overall, the COVID-19 pandemic has not been a major precipitating factor nor has it affected the seizure control status of PWE. In treated epilepsy, a fluctuating course with periods of seizure freedom followed by relapses is part of its natural history. 


  1. Sperling MR, Schilling CA, Glosser D, Tracy JI, Asadi-Pooya AA. Self-perception of seizure precipitants and their relation to anxiety level, depression, and health locus of control in epilepsy. Seizure. 2008;17:302-7. doi: 10.1016/j.seizure.2007.09.003. PubMed PMID: 17977026.
  2. Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020;109:102433. doi: 10.1016/j.jaut.2020.102433. PubMed PMID: 32113704; PubMed Central PMCID: PMCPMC7127067.
  3. COVID-19 pandemic in Iran [Internet]. [Accessed 26 November 2021]. Available from:
  4. Asadi-Pooya AA, Simani L, Shahisavandi M, Barzegar Z. COVID-19, de novo seizures, and epilepsy: a systematic review. Neurol Sci. 2021;42:415-31. doi: 10.1007/s10072-020-04932-2. PubMed PMID: 33237493; PubMed Central PMCID: PMCPMC7686454.
  5. Luo M, Guo L, Yu M, Jiang W, Wang H. The psychological and mental impact of coronavirus disease 2019 (COVID-19) on medical staff and general public - A systematic review and meta-analysis. Psychiatry Res. 2020;291:113190. doi: 10.1016/j.psychres.2020.113190. PubMed PMID: 32563745; PubMed Central PMCID: PMCPMC7276119.
  6. Granata T, Bisulli F, Arzimanoglou A, Rocamora R. Did the COVID-19 pandemic silence the needs of people with epilepsy? Epileptic Disord. 2020;22:439-42. doi: 10.1684/epd.2020.1175. PubMed PMID: 32759092; PubMed Central PMCID: PMCPMC7537265.
  7. Miller WR, Von Gaudecker J, Tanner A, Buelow JM. Epilepsy self-management during a pandemic: Experiences of people with epilepsy. Epilepsy Behav. 2020;111:107238. doi: 10.1016/j.yebeh.2020.107238. PubMed PMID: 32593874; PubMed Central PMCID: PMCPMC7316066.
  8. Asadi-Pooya AA, Farazdaghi M, Bazrafshan M. Impacts of the COVID-19 pandemic on Iranian patients with epilepsy. Acta Neurol Scand. 2020;142:392-5. doi: 10.1111/ane.13310. PubMed PMID: 32632917; PubMed Central PMCID: PMCPMC7362008.
  9. Aledo-Serrano A, Mingorance A, Jimenez-Huete A, Toledano R, Garcia-Morales I, Anciones C, et al. Genetic epilepsies and COVID-19 pandemic: Lessons from the caregiver perspective. Epilepsia. 2020;61:1312-4. doi: 10.1111/epi.16537. PubMed PMID: 32420620; PubMed Central PMCID: PMCPMC7276740.
  10. Assenza G, Lanzone J, Brigo F, Coppola A, Di Gennaro G, Di Lazzaro V, et al. Epilepsy Care in the Time of COVID-19 Pandemic in Italy: Risk Factors for Seizure Worsening. Front Neurol. 2020;11:737. doi: 10.3389/fneur.2020.00737. PubMed PMID: 32719655; PubMed Central PMCID: PMCPMC7350269.
  11. Alkhotani A, Siddiqui MI, Almuntashri F, Baothman R. The effect of COVID-19 pandemic on seizure control and self-reported stress on patient with epilepsy. Epilepsy Behav. 2020;112:107323. doi: 10.1016/j.yebeh.2020.107323. PubMed PMID: 32712565; PubMed Central PMCID: PMCPMC7359799.
  12. Cabona C, Deleo F, Marinelli L, Audenino D, Arnaldi D, Rossi F, et al. Epilepsy course during COVID-19 pandemic in three Italian epilepsy centers. Epilepsy Behav. 2020;112:107375. doi: 10.1016/j.yebeh.2020.107375. PubMed PMID: 32858368; PubMed Central PMCID: PMCPMC7445187.
  13. Koh MY, Lim KS, Fong SL, Khor SB, Tan CT. Impact of COVID-19 pandemic on people with epilepsy: An interventional study using early physical consultation. Epilepsy Behav. 2021;122:108215. doi: 10.1016/j.yebeh.2021.108215. PubMed PMID: 34325157; PubMed Central PMCID: PMCPMC8270747.
  14. Guilhoto LM, Mosini AC, Susemihl MA, Pinto LF. COVID-19 and epilepsy: How are people with epilepsy in Brazil? Epilepsy Behav. 2021;122:108115. doi: 10.1016/j.yebeh.2021.108115. PubMed PMID: 34144461; PubMed Central PMCID: PMCPMC8412880.
  15. Kuroda N, Fujimoto A. Considering temporality in causal relationship between seizure worsening and psychological stress in patients with epilepsy during the COVID-19 pandemic: A systematic review. Epilepsy Behav. 2021;122:108184. doi: 10.1016/j.yebeh.2021.108184. PubMed PMID: 34252833.
  16. Brodie MJ, Barry SJ, Bamagous GA, Norrie JD, Kwan P. Patterns of treatment response in newly diagnosed epilepsy. Neurology. 2012;78:1548-54. doi: 10.1212/WNL.0b013e3182563b19. PubMed PMID: 22573629; PubMed Central PMCID: PMCPMC3348850.
  17. Sperling MR, Nei M, Zangaladze A, Sharan AD, Mintzer SE, Skidmore C, et al. Prognosis after late relapse following epilepsy surgery. Epilepsy Res. 2008;78:77-81. doi: 10.1016/j.eplepsyres.2007.10.011. PubMed PMID: 18077135.
  18. Asadi-Pooya AA. Seizures associated with coronavirus infections. Seizure. 2020;79:49-52. doi: 10.1016/j.seizure.2020.05.005. PubMed PMID: 32416567; PubMed Central PMCID: PMCPMC7212943.
  19. Keshavarzi A, Janbabaei G, Kheyrati L, Ghavamabad LH, Asadi-Pooya AA. Seizure is a rare presenting manifestation of COVID-19. Seizure. 2021;86:16-8. doi: 10.1016/j.seizure.2021.01.009. PubMed PMID: 33515905; PubMed Central PMCID: PMCPMC7825948.
  20. Asadi-Pooya AA, Shahisavandi M, Sadeghian S, Nezafat A, Nabavizadeh SA, Barzegar Z. Is the risk of COVID-19 contraction increased in patients with epilepsy? Epilepsy Behav. 2021;115:107734. doi: 10.1016/j.yebeh.2020.107734. PubMed PMID: 33450616; PubMed Central PMCID: PMCPMC7831817.
  21. Asadi-Pooya AA, Emami A, Akbari A, Javanmardi F. COVID-19 presentations and outcome in patients with epilepsy. Acta Neurol Scand. 2021;143:624-8. doi: 10.1111/ane.13404. PubMed PMID: 33590880; PubMed Central PMCID: PMCPMC8014655.
  22. Beniczky S, Husain A, Ikeda A, Alabri H, Helen Cross J, Wilmshurst J, et al. Importance of access to epilepsy monitoring units during the COVID-19 pandemic: Consensus statement of the International League against epilepsy and the International Federation of Clinical Neurophysiology. Clin Neurophysiol. 2021;132:2248-50. doi: 10.1016/j.clinph.2021.05.001. PubMed PMID: 34275732; PubMed Central PMCID: PMCPMC8294085.